These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7559796)

  • 21. Auto-induction and growth stimulatory effect of betacellulin in human pancreatic cancer cells.
    Kawaguchi M; Hosotani R; Kogire M; Ida J; Doi R; Koshiba T; Miyamoto Y; Tsuji S; Nakajima S; Kobayashi H; Masui T; Imamura M
    Int J Oncol; 2000 Jan; 16(1):37-41. PubMed ID: 10601546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
    Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
    J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells.
    Sun L; Wu S; Coleman K; Fields KC; Humphrey LE; Brattain MG
    Exp Cell Res; 1994 Sep; 214(1):215-24. PubMed ID: 8082724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II.
    Rutten AA; Bermudez E; Stewart W; Everitt JI; Walker CL
    Cancer Res; 1995 Aug; 55(16):3634-9. PubMed ID: 7627973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model.
    Coffey RJ; Goustin AS; Soderquist AM; Shipley GD; Wolfshohl J; Carpenter G; Moses HL
    Cancer Res; 1987 Sep; 47(17):4590-4. PubMed ID: 2887281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Src stimulates insulin-like growth factor I (IGF-I)-dependent cell proliferation by increasing IGF-I receptor number in human pancreatic carcinoma cells.
    Flossmann-Kast BB; Jehle PM; Hoeflich A; Adler G; Lutz MP
    Cancer Res; 1998 Aug; 58(16):3551-4. PubMed ID: 9721859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulin receptors.
    Osipo C; Dorman S; Frankfater A
    Exp Cell Res; 2001 Apr; 264(2):388-96. PubMed ID: 11262195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of and response to growth regulatory peptides by two human pancreatic carcinoma cell lines.
    Beauchamp RD; Lyons RM; Yang EY; Coffey RJ; Moses HL
    Pancreas; 1990 Jul; 5(4):369-80. PubMed ID: 2199964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells.
    Scott CD; Weiss J
    J Cell Physiol; 2000 Jan; 182(1):62-8. PubMed ID: 10567917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells.
    Chang J; Park K; Bang YJ; Kim WS; Kim D; Kim SJ
    Cancer Res; 1997 Jul; 57(14):2856-9. PubMed ID: 9230189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in corneal fibroblasts during corneal wound healing.
    Izumi K; Kurosaka D; Iwata T; Oguchi Y; Tanaka Y; Mashima Y; Tsubota K
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):591-8. PubMed ID: 16431955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M; Oyasu R
    Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
    Ko Y; Banerji SS; Liu Y; Li W; Liang J; Soule HD; Pauley RJ; Willson JK; Zborowska E; Brattain MG
    J Cell Physiol; 1998 Aug; 176(2):424-34. PubMed ID: 9648930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells.
    Steller MA; Delgado CH; Bartels CJ; Woodworth CD; Zou Z
    Cancer Res; 1996 Apr; 56(8):1761-5. PubMed ID: 8620490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of avian precardiac mesoderm development by insulin and insulin-like growth factors.
    Antin PB; Yatskievych T; Dominguez JL; Chieffi P
    J Cell Physiol; 1996 Jul; 168(1):42-50. PubMed ID: 8647921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
    Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotensin receptor-mediated inhibition of pancreatic cancer cell growth by the neurotensin antagonist SR 48692.
    Herzig MC; Chapman WG; Sheridan A; Rake JB; Woynarowski JM
    Anticancer Res; 1999; 19(1A):213-9. PubMed ID: 10226545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.